[Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
D000085:Acetates / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000568:Amenorrhea / Q000209:etiology; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006879:Hydroxocobalamin / Q000627:therapeutic use; D007154:Immune System Diseases / Q000209:etiology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000453:epidemiology; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D012737:Sex Factors; D013997:Time Factors
D000085:Acetates; D002699:Chlorambucil; D000324:Adrenocorticotropic Hormone; D006879:Hydroxocobalamin; D011241:Prednisone; D008775:Methylprednisolone
Etude critique du traitment de la sclérose en plaques par le chlorambucil et la corticothérapie intrarachidienne. A propos de 100 cas suivis pendant une péroide comprise entre 2 et 9 ans